Effect of calcitriol in infectio
Phase 3
Completed
- Conditions
- positive systemic inflammatory response.
- Registration Number
- IRCT20180522039777N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
all positive SIRS patients greater than or equal to 18 years with suspicion to infection that antibiotics have been started for them
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improved in procalcitonin marker. Timepoint: Marker measurements at day 0, 3 and 5 after calcitriol injection. Method of measurement: Reduce symptoms of inflammation.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does calcitriol modulate vitamin D receptor pathways to reduce Procalcitonin in systemic inflammatory response?
What comparative efficacy data exist for calcitriol versus corticosteroids in sepsis biomarker suppression?
Which biomarkers correlate with calcitriol response in IRCT20180522039777N1 sepsis trials?
What are the safety profiles of calcitriol in phase III trials for hypercalcemia management?
How do vitamin D analogs like calcitriol compare to other immunomodulators in sepsis treatment strategies?